Sökning: (WFRF:(David Siegelin Markus)) > Designing a broad-s...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 27258naa a2202509 4500 | |
001 | oai:DiVA.org:liu-123767 | |
003 | SwePub | |
008 | 160111s2015 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:132616666 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1237672 URI |
024 | 7 | a https://doi.org/10.1016/j.semcancer.2015.09.0072 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1326166662 URI |
040 | a (SwePub)liud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a for2 swepub-publicationtype |
100 | 1 | a Block, Keith I.u Block Centre Integrat Cancer Treatment, IL 60077 USA4 aut |
245 | 1 0 | a Designing a broad-spectrum integrative approach for cancer prevention and treatment |
264 | 1 | b Academic Press,c 2015 |
338 | a electronic2 rdacarrier | |
500 | a Funding Agencies|Terry Fox Foundation Grant [TF-13-20]; UAEU Program for Advanced Research (UPAR) [31S118]; NIH [AR47901, R21CA188818, R15 CA137499-01, F32CA177139, P20RR016477, P20GM103434, R01CA170378, U54CA149145, U54CA143907, R01-HL107652, R01CA166348, R01GM071725, R01 CA109335-04A1, 109511R01CA151304CA168997 A11106131R03CA1711326 1P01AT003961RO1 CA100816P01AG034906 R01AG020642P01AG034906-01A1R01HL108006]; NIH NRSA Grant [F31CA154080]; NIH (NIAID) R01: Combination therapies for chronic HBV, liver disease, and cancer [AI076535]; Sky Foundation Inc. Michigan; University of Glasgow; Beatson Oncology Centre Fund; Spanish Ministry of Economy and Competitivity, ISCIII [PI12/00137, RTICC: RD12/0036/0028]; FEDER from Regional Development European Funds (European Union), Consejeria de Ciencia e Innovacion [CTS-6844, CTS-1848]; Consejeria de Salud of the Junta de Andalucia [PI-0135-2010, PI-0306-2012]; ISCIII [PIE13/0004]; FEDER funds; United Soybean Board; NIH NCCAM Grant [K01AT007324]; NIH NCI Grant [R33 CA161873-02]; Michael Cuccione Childhood Cancer Foundation Graduate Studentship; Ovarian and Prostate Cancer Research Trust, UK; West Virginia Higher Education Policy Commission/Division of Science Research; National Institutes of Health; Italian Association for Cancer Research (AIRC) [IG10636, 15403]; GRACE Charity, UK; Breast Cancer Campaign, UK; Michael Cuccione Childhood Cancer Foundation Postdoctoral Fellowship; Connecticut State University; Swedish Research Council; Swedish Research Society; University of Texas Health Science Centre at Tyler, Elsa U. Pardee Foundation; CPRIT; Cancer Prevention and Research Institute of Texas; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH National Institute on Alcohol Abuse and Alcoholism (NIAAA); Gilead and Shire Pharmaceuticals; NIH/NCI [1R01CA20009, 5R01CAl27258-05, R21CA184788, NIH P30 CA22453, NCI RO1 28704]; Scottish Governments Rural and Environment Science and Analytical Services Division; National Research Foundation; United Arab Emirates University; Terry Fox Foundation; Novartis Pharmaceutical; Aveo Pharmaceutical; Roche; Bristol Myers Squibb; Bayer Pharmaceutical; Pfizer; Kyowa Kirin; NIH/NIAID Grant [A1076535]; Auckland Cancer Society; Cancer Society of New Zealand; NIH Public Service Grant from the National Cancer Institute [CA164095]; Medical Research Council CCU-Program Grant on cancer metabolism; EU Marie Curie Reintegration Grant [MC-CIG-303514]; Greek National funds through the Operational Program Educational and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program THALES [MIS 379346]; COST Action CM1201 `Biomimetic Radical Chemistry; Duke University Molecular Cancer Biology T32 Training Grant; National Sciences Engineering and Research Council Undergraduate Student Research Award in Canada; Charles University in Prague projects [UNCE 204015, PRVOUK P31/2012]; Czech Science Foundation projects [15-03834Y, P301/12/1686]; Czech Health Research Council AZV project [15-32432A]; Internal Grant Agency of the Ministry of Health of the Czech Republic project [NT13663-3/2012]; National Institute of Aging [P30AG028716-01]; NIH/NCI training grants to Duke University [T32-CA059365-19, 5T32-CA059365]; Ministry of Education, Culture, Sports, Science and Technology, Japan [24590493]; Ministry of Health and Welfare [CCMP101-RD-031, CCMP102-RD-112]; Tzu-Chi University of Taiwan [61040055-10]; Svenska Sallskapet for Medicinsk Forskning; Cancer Research Wales; Albert Hung Foundation; Fong Family Foundation; Welsh Government A4B scheme; NIH NCI; University of Glasgow, Beatson Oncology Centre Fund, CRUK [C301/A14762]; NIH Intramural Research Program; National Science Foundation; American Cancer Society; National Cancer Center [NCC-1310430-2]; National Research Foundation [NRF-2005-0093837]; Sol Goldman Pancreatic Cancer Research Fund Grant [80028595]; Lustgarten Fund Grant [90049125, NIHR21CA169757]; Alma Toorock Memorial for Cancer Research; National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea [2011-0017639, 2011-0030001]; Ministry of Education of Taiwan [TMUTOP103005-4]; International Life Sciences Institute; United States Public Health Services Grants [NIH R01CA156776]; VA-BLR&D Merit Review Grant [5101-BX001517-02]; V Foundation; Pancreatic Cancer Action Network; Damon Runyon Cancer Research Foundation; Childrens Cancer Institute Australia; University Roma Tre; Italian Association for Cancer Research (AIRC-Grant) [IG15221]; Carlos III Health Institute; Feder funds [AM: CP10/00539, PI13/02277]; Basque Foundation for Science (IKERBASQUE); Marie Curie CIG Grant [2012/712404]; Canadian Institutes of Health Research; Avon Foundation for Women [OBC-134038]; Canadian Institutes of Health [MSH-136647, MOP 64308]; Bayer Healthcare System G4T (Grants4Targets); NIH NIDDK; NIH NIAAA; Shire Pharmaceuticals; Harvard-MIT Health Sciences and Technology Research Assistantship Award; Italian Ministry of University; University of Italy; Auckland Cancer Society Research Centre (ACSRC); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [16SV5536K]; European Commission [FP7 259679 "IDEAL"]; Cinque per Mille dellIRPEF-Finanziamento della Ricerca Sanitaria; European Union Seventh Framework Programme (FP7) [278570]; AIRC [10216, 13837]; European Communitys Seventh Framework Program FP7 [311876]; Canadian Institute for Health Research [MOP114962, MOP125857]; Fonds de Recherche Quebec Sante [22624]; Terry Fox Research Institute [1030]; FEDER; MICINN [SAF2012-32810]; Junta de Castilla y Leon [BIO/SA06/13]; ARIMMORA project [FP7-ENV-2011]; European Union; NIH NIDDK [K01DK077137, R03DK089130]; NIH NCI grants [R01CA131294, R21 CA155686]; Avon Foundation; Breast Cancer Research Foundation Grant [90047965]; National Institute of Health, NINDS Grant [K08NS083732]; AACR-National Brain Tumor Society Career Development Award for Translational Brain Tumor Research [13-20-23-SIEG]; Department of Science and Technology, New Delhi, India [SR/FT/LS-063/2008]; Yorkshire Cancer Research; Wellcome Trust, UK; Italian Ministry of Economy and Finance Project CAMPUS-QUARC, within program FESR Campania Region; National Cancer Institute [5P01CA073992]; IDEA Award from the Department of Defense [W81XWH-12-1-0515]; Huntsman Cancer Foundation; University of Miami Clinical and Translational Science Institute (CTSI) Pilot Research Grant [CTSI-2013-P03]; SEEDS You Choose Awards; DoD [W81XVVH-11-1-0272, W81XWH-13-1-0182]; Kimmel Translational Science Award [SKF-13-021]; ACS Scholar award [122688-RSG-12-196-01-TBG]; National Cancer Institute, Pancreatic Cancer Action Network, Pew Charitable Trusts; American Diabetes Association; Elsa U. Pardee Foundation; Scientific Research Foundation for the Returned Oversea Scholars, State Education Ministry and Scientific and Technological Innovation Project, Harbin [2012RFLX5011]; United States National Institutes of Health [ES019458]; California Breast Cancer Research Program [17UB-8708]; National Institutes of Health through the RCMI-Center for Environmental Health [G1200MD007581]; NIH/National Heart, Lung, and Blood Institute Training Grant [T32HL098062]; European FP7-TuMIC [HEALTH-F2-2008-201662]; Italian Association for Cancer research (AIRC) Grant IG [11963]; Regione Campania L.R:N.5; European National Funds [PON01-02388/1 2007-2013] | |
520 | a Targeted therapies and the consequent adoption of "personalized" oncology have achieved notable successes in some cancers; however, significant problems remain with this approach. Many targeted therapies are highly toxic, costs are extremely high, and most patients experience relapse after a few disease-free months. Relapses arise from genetic heterogeneity in tumors, which harbor therapy-resistant immortalized cells that have adopted alternate and compensatory pathways (i.e., pathways that are not reliant upon the same mechanisms as those which have been targeted). To address these limitations, an international task force of 180 scientists was assembled to explore the concept of a low-toxicity "broadspectrum" therapeutic approach that could simultaneously target many key pathways and mechanisms. Using cancer hallmark phenotypes and the tumor microenvironment to account for the various aspects of relevant cancer biology, interdisciplinary teams reviewed each hallmark area and nominated a wide range of high-priority targets (74 in total) that could be modified to improve patient outcomes. For these targets, corresponding low-toxicity therapeutic approaches were then suggested, many of which were phytochemicals. Proposed actions on each target and all of the approaches were further reviewed for known effects on other hallmark areas and the tumor microenvironment Potential contrary or procarcinogenic effects were found for 3.9% of the relationships between targets and hallmarks, and mixed evidence of complementary and contrary relationships was found for 7.1%. Approximately 67% of the relationships revealed potentially complementary effects, and the remainder had no known relationship. Among the approaches, 1.1% had contrary, 2.8% had mixed and 62.1% had complementary relationships. These results suggest that a broad-spectrum approach should be feasible from a safety standpoint. This novel approach has potential to be relatively inexpensive, it should help us address stages and types of cancer that lack conventional treatment, and it may reduce relapse risks. A proposed agenda for future research is offered. (C) 2015 The Authors. Published by Elsevier Ltd. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Multi-targeted; Cancer hallmarks; Phytochemicals; Targeted therapy; Integrative medicine | |
700 | 1 | a Gyllenhaal, Charlotteu Block Centre Integrat Cancer Treatment, IL 60077 USA; National Cancer Centre, South Korea4 aut |
700 | 1 | a Lowe, Leroyu Getting Know Canc, Canada; University of Lancaster, England,University of Bologna, Italy,Georgia Regents University, GA USA,Childrens Cancer Institute Australia, Australia,Technology Pk Bizkaia, Spain,Johns Hopkins University, MD USA,St Lukes Roosevelt Hospital, NY 10025 USA4 aut |
700 | 1 | a Amedei, Amedeou University of Florence, Italy,University of N Carolina, NC 27599 USA,University of Windsor, Canada,Rutgers State University, NJ USA,University of Michigan, MI USA; University of Michigan, MI USA,Duke University, NC 27710 USA4 aut |
700 | 1 | a Ruhul Amin, A. R. M.u University of Florence, Italy,University of Roma Tor Vergata, Italy,University of N Carolina, NC 27599 USA,McGill University, Canada,Biodonostia Institute, Spain,Cornell University, NY USA,United Arab Emirates University, U Arab Emirates4 aut |
700 | 1 | a Amin, Amru University of Florence, Italy4 aut |
700 | 1 | a Aquilano, Katiau United Arab Emirates University, U Arab Emirates4 aut |
700 | 1 | a Arbiser, Jacku Atlanta Vet Adm Medical Centre, GA USA; Emory University, GA USA4 aut |
700 | 1 | a Arreola, Alexandrau University of Roma Tor Vergata, Italy4 aut |
700 | 1 | a Arzumanyan, Allau University of N Carolina, NC 27599 USA4 aut |
700 | 1 | a Salman Ashraf, S.u Temple University, PA 19122 USA,Columbia University, NY USA; University of Penn, PA 19104 USA4 aut |
700 | 1 | a Azmi, Asfar S.u United Arab Emirates University, U Arab Emirates4 aut |
700 | 1 | a Benencia, Fabianu Wayne State University, MI USA4 aut |
700 | 1 | a Bhakta, Dipitau Ohio University, OH 45701 USA4 aut |
700 | 1 | a Bilsland, Alanu SASTRA University, India4 aut |
700 | 1 | a Bishayeen, Anupamu University of Glasgow, Scotland4 aut |
700 | 1 | a Blain, Stacy W.u Larkin Health Science Institute, FL USA4 aut |
700 | 1 | a Block, Penny B.u Block Centre Integrat Cancer Treatment, IL 60077 USA4 aut |
700 | 1 | a Boosani, Chandra S.u Suny Downstate Medical Centre, NY USA4 aut |
700 | 1 | a Carey, Thomas E.u Creighton University, NE 68178 USA,United Arab Emirates University, U Arab Emirates4 aut |
700 | 1 | a Carnero, Amanciou University of Michigan, MI USA4 aut |
700 | 1 | a Carotenuto, Marianeveu CSIC, Spain; Centre Ingn Genet and Biotecnol Avanzate, Italy,St Lukes Roosevelt Hospital, NY 10025 USA4 aut |
700 | 1 | a Casey, Stephanie C.u University of Naples Federico II, Italy4 aut |
700 | 1 | a Chakrabarti, Mrinmayu Stanford University, CA 94305 USA4 aut |
700 | 1 | a Chaturvedi, Rupeshu University of S Carolina, SC USA4 aut |
700 | 1 | a Zhuo Chen, Georgiau Winship Cancer Institute of Emory University, Atlanta, GA, United States4 aut |
700 | 1 | a Chenx, Helenu Jawaharlal Nehru University, India4 aut |
700 | 1 | a Chen, Sophieu University of British Columbia, Canada4 aut |
700 | 1 | a Charlie Chen, Yiu Ovarian and Prostate Cancer Research Lab, England; Alderson Broaddus University, PA USA4 aut |
700 | 1 | a Choi, Beom K.u National Cancer Centre, South Korea4 aut |
700 | 1 | a Rosa Ciriolo, Mariau United Arab Emirates University, U Arab Emirates4 aut |
700 | 1 | a Coley, Helen M.u University of Surrey, England4 aut |
700 | 1 | a Collins, Andrew R.u University of Oslo, Norway4 aut |
700 | 1 | a Connell, Marisau Jawaharlal Nehru University, India4 aut |
700 | 1 | a Crawford, Sarahu So Connecticut State University, CT 06515 USA4 aut |
700 | 1 | a Curran, Colleen S.u University of Wisconsin, WI USA4 aut |
700 | 1 | a Dabrosin, Charlottau Linköpings universitet,Avdelningen för kliniska vetenskaper,Medicinska fakulteten,Region Östergötland, Onkologiska kliniken US4 aut0 (Swepub:liu)chada67 |
700 | 1 | a Damia, Giovannau Ist Ric Farmacol Mario Negri, Italy4 aut |
700 | 1 | a Dasgupta, Santanuu University of Texas Health Science Centre Tyler, TX USA4 aut |
700 | 1 | a DeBerardinis, Ralph J.u University of Texas SW Medical Centre Dallas, TX 75390 USA4 aut |
700 | 1 | a Decker, William K.u Baylor Coll Med, TX 77030 USA4 aut |
700 | 1 | a Dhawan, Punitau Vanderbilt University, TN 37212 USA4 aut |
700 | 1 | a Diehl, Anna Mae E.u Duke University, NC 27710 USA4 aut |
700 | 1 | a Dong, Jin-Tangu Winship Cancer Institute of Emory University, Atlanta, GA, United States,Nara Medical University, Japan4 aut |
700 | 1 | a Ping Dou, Q.u United Arab Emirates University, U Arab Emirates4 aut |
700 | 1 | a Drew, Janice E.u University of Aberdeen, Scotland4 aut |
700 | 1 | a Elkord, Eyadu United Arab Emirates University, U Arab Emirates,University of Miami, FL USA,Columbia University, NY USA; University of Penn, PA 19104 USA4 aut |
700 | 1 | a El-Rayes, Basselu Emory University, GA 30322 USA4 aut |
700 | 1 | a Feitelson, Mark A.u University of N Carolina, NC 27599 USA4 aut |
700 | 1 | a Felsher, Dean W.u University of Naples Federico II, Italy4 aut |
700 | 1 | a Ferguson, Lynnette R.u University of Auckland, New Zealand4 aut |
700 | 1 | a Fimognari, Carmelau University of Auckland, New Zealand4 aut |
700 | 1 | a Firestone, Gary L.u University of Bologna, Italy4 aut |
700 | 1 | a Frezza, Christianu University of Calif Berkeley, CA 94720 USA4 aut |
700 | 1 | a Fujii, Hiromasau University of Cambridge, England4 aut |
700 | 1 | a Fuster, Mark M.u Nara Medical University, Japan4 aut |
700 | 1 | a Generali, Danieleu University of Calif San Diego, CA 92103 USA; University of Calif San Diego, CA 92103 USA4 aut |
700 | 1 | a Georgakilas, Alexandros G.u University of Trieste, Italy,Ohio University, OH 45701 USA4 aut |
700 | 1 | a Gieseler, Franku Azienda Osped Ist Ospitalieri Cremona, Italy4 aut |
700 | 1 | a Gilbertson, Michaelu National Technical University of Athens, Greece4 aut |
700 | 1 | a Green, Michelle F.u University Hospital Schleswig Holstein, Germany4 aut |
700 | 1 | a Grue, Brendanu Getting Know Canc, Canada4 aut |
700 | 1 | a Guha, Gunjanu Ohio University, OH 45701 USA,Dalhousie University, Canada,Cardiff University, Wales,MIT, MA 02139 USA4 aut |
700 | 1 | a Halicka, Dorotau Duke University, NC USA4 aut |
700 | 1 | a Helferich, William G.u Dalhousie University, Canada4 aut |
700 | 1 | a Heneberg, Petru New York Medical Coll, NY 10595 USA,Institute Cancer Montreal, Canada4 aut |
700 | 1 | a Hentosh, Patriciau University of Illinois, IL 61820 USA4 aut |
700 | 1 | a Hirschey, Matthew D.u University Hospital Schleswig Holstein, Germany4 aut |
700 | 1 | a Hofseth, Lorne J.u Charles University of Prague, Czech Republic4 aut |
700 | 1 | a Holcombe, Randall F.u Old Domin University, VA USA4 aut |
700 | 1 | a Honoki, Kanyau Department of Orthopedic Surgery, Nara Medical University, Kashihara, Nara, Japan4 aut |
700 | 1 | a Hsu, Hsue-Yinu University of S Carolina, SC 29208 USA4 aut |
700 | 1 | a Huang, Gloria S.u Mt Sinai School Med, NY USA4 aut |
700 | 1 | a Jensen, Lasse D.u Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten4 aut0 (Swepub:liu)larje86 |
700 | 1 | a Jiang, Wen G.u Cardiff University, Wales4 aut |
700 | 1 | a Jones, Lee W.u Mem Sloan Kettering Cancer Centre, NY 10021 USA4 aut |
700 | 1 | a Karpowicz, Phillip A.u University of Windsor, Canada4 aut |
700 | 1 | a Nicol Keith, W.u SASTRA University, India4 aut |
700 | 1 | a Kerkar, Sid P.u Mayo Clin, MN USA4 aut |
700 | 1 | a Khan, Gazala N.u Henry Ford Hospital, MI 48202 USA4 aut |
700 | 1 | a Khatami, Mahinu National Institute Heatlh, MD USA4 aut |
700 | 1 | a Ko, Young H.u University of Maryland BioPark, MD USA4 aut |
700 | 1 | a Kucuk, Omeru Winship Cancer Institute of Emory University, Atlanta, GA, United States4 aut |
700 | 1 | a Kulathinal, Rob J.u University of N Carolina, NC 27599 USA4 aut |
700 | 1 | a Kumar, Nagi B.u University of S Florida, FL USA4 aut |
700 | 1 | a Kwon, Byoung S.u National Cancer Centre, South Korea; Tulane University, LA 70118 USA4 aut |
700 | 1 | a Le, Anneu Johns Hopkins University, MD USA4 aut |
700 | 1 | a Lea, Michael A.u Rutgers State University, NJ USA4 aut |
700 | 1 | a Lee, Ho-Youngu Seoul National University, South Korea4 aut |
700 | 1 | a Lichtor, Terryu Rush University, IL 60612 USA4 aut |
700 | 1 | a Lin, Liang-Tzungu Taipei Medical University, Taiwan4 aut |
700 | 1 | a Locasale, Jason W.u Cornell University, NY 14853 USA4 aut |
700 | 1 | a Lokeshwar, Bal L.u Georgia Regents University, GA USA4 aut |
700 | 1 | a Longo, Valter D.u University of So Calif, CA USA4 aut |
700 | 1 | a Lyssiotis, Costas A.u University of Michigan, MI USA; University of Michigan, MI USA4 aut |
700 | 1 | a MacKenzie, Karen L.u Childrens Cancer Institute Australia, Australia4 aut |
700 | 1 | a Malhotra, Meenakshiu McGill University, Canada,Winship Cancer Institute of Emory University, Atlanta, GA, United States,University of Utah, UT USA4 aut |
700 | 1 | a Marino, Mariau University of Rome Tre, Italy4 aut |
700 | 1 | a Martinez-Chantar, Maria L.u Technology Pk Bizkaia, Spain4 aut |
700 | 1 | a Matheu, Anderu Biodonostia Institute, Spain4 aut |
700 | 1 | a Maxwell, Christopheru Jawaharlal Nehru University, India4 aut |
700 | 1 | a McDonnell, Eoinu University Hospital Schleswig Holstein, Germany4 aut |
700 | 1 | a Meeker, Alan K.u Johns Hopkins University, MD 21205 USA4 aut |
700 | 1 | a Mehrmohamadi, Mahyau Cornell University, NY USA4 aut |
700 | 1 | a Mehta, Kapilu University of Texas MD Anderson Cancer Centre, TX 77030 USA4 aut |
700 | 1 | a Michelotti, Gregory A.u Duke University, NC 27710 USA4 aut |
700 | 1 | a Mohammad, Ramzi M.u United Arab Emirates University, U Arab Emirates4 aut |
700 | 1 | a Mohammed, Sulma I.u Purdue University, IN 47907 USA4 aut |
700 | 1 | a James Morre, D.u Mor NuCo Inc, IN USA4 aut |
700 | 1 | a Muqbil, Irfanau United Arab Emirates University, U Arab Emirates4 aut |
700 | 1 | a Muralidhar, Vinayaku Harvard University, MA USA; MIT, MA 02139 USA4 aut |
700 | 1 | a Murphy, Michael P.u MRC Mitochondrial Biol Unit, England4 aut |
700 | 1 | a Purnachandra Nagaraju, Ganjiu Emory University, GA 30322 USA4 aut |
700 | 1 | a Nahta, Ritau Winship Cancer Institute of Emory University, Atlanta, GA, United States4 aut |
700 | 1 | a Niccolai, Elenau University of Florence, Italy4 aut |
700 | 1 | a Nowsheen, Somairau Mayo Clin, MN USA4 aut |
700 | 1 | a Panis, Carolinau State University of West Parana, Brazil4 aut |
700 | 1 | a Pantano, Francescou University of Campus Bio Med, Italy4 aut |
700 | 1 | a Parslow, Virginia R.u University of Auckland, New Zealand4 aut |
700 | 1 | a Pawelec, Grahamu University of Tubingen, Germany4 aut |
700 | 1 | a Pedersen, Peter L.u Johns Hopkins University, MD USA4 aut |
700 | 1 | a Poore, Bradu Johns Hopkins University, MD USA4 aut |
700 | 1 | a Poudyal, Deepaku Charles University of Prague, Czech Republic4 aut |
700 | 1 | a Prakash, Satyau McGill University, Canada4 aut |
700 | 1 | a Prince, Marku University of Michigan, MI USA4 aut |
700 | 1 | a Raffaghello, Lizziau Ist Giannina Gaslini, Italy4 aut |
700 | 1 | a Rathmell, Jeffrey C.u University Hospital Schleswig Holstein, Germany4 aut |
700 | 1 | a Kimryn Rathmell, W.u University of Roma Tor Vergata, Italy4 aut |
700 | 1 | a Ray, Swapan K.u Stanford University, CA 94305 USA4 aut |
700 | 1 | a Reichrath, Joergu Saarland University Hospital, Germany4 aut |
700 | 1 | a Rezazadeh, Sarallahu University of Rochester, NY 14627 USA4 aut |
700 | 1 | a Ribatti, Domenicou University of Bari, Italy4 aut |
700 | 1 | a Ricciardiello, Luigiu National Cancer Institute Giovanni Paolo II, Italy4 aut |
700 | 1 | a Brooks Robey, R.u University of Bologna, Italy; White River Junct Vet Affairs Medical Centre, VT USA4 aut |
700 | 1 | a Rodier, Francisu Geisel School Medical Dartmouth, NH USA; University of Montreal, Canada4 aut |
700 | 1 | a Vasantha Rupasinghe, H. P.u Institute Cancer Montreal, Canada4 aut |
700 | 1 | a Luigi Russo, Gianu University of Montreal, Canada4 aut |
700 | 1 | a Ryan, Elizabeth P.u Dalhousie University, Canada4 aut |
700 | 1 | a Samadi, Abbas K.u Sanus Biosciences, San Diego, CA, United States4 aut |
700 | 1 | a Sanchez-Garcia, Isidrou CNR, Italy4 aut |
700 | 1 | a Sanders, Andrew J.u Cardiff University, Wales4 aut |
700 | 1 | a Santini, Danieleu University of Campus Bio Med, Italy4 aut |
700 | 1 | a Sarkar, Malanchau Colorado State University, CO 80523 USA4 aut |
700 | 1 | a Sasada, Tetsurou Department of Immunology, Kurume University School of Medicine, Kurume, Fukuoka, Japan4 aut |
700 | 1 | a Saxena, Neeraj K.u University of Salamanca, Spain4 aut |
700 | 1 | a Shackelford, Rodney E.u University of Miami, FL USA4 aut |
700 | 1 | a Shantha Kumara, H. M. C.u St Lukes Roosevelt Hospital, NY 10025 USA4 aut |
700 | 1 | a Sharma, Dipaliu Kurume University, Japan4 aut |
700 | 1 | a Shin, Dong M.u Winship Cancer Institute of Emory University, Atlanta, GA, United States4 aut |
700 | 1 | a Sidransky, Davidu University of Maryland, MD 21201 USA4 aut |
700 | 1 | a David Siegelin, Markusu Louisiana State University, LA 71105 USA4 aut |
700 | 1 | a Signori, Emanuelau Johns Hopkins University, MD 21205 USA; Johns Hopkins University, MD USA4 aut |
700 | 1 | a Singh, Neetuu Johns Hopkins University, MD USA; King Georges Medical University, India4 aut |
700 | 1 | a Sivanand, Sharanyau Columbia University, NY USA; University of Penn, PA 19104 USA,Tulane University, LA USA,University of Alabama Birmingham, AL USA4 aut |
700 | 1 | a Sliva, Danielu Institute Translat Pharmacol, Italy; Purdue Research Pk, IN USA4 aut |
700 | 1 | a Smythe, Carlu University of Sheffield, England4 aut |
700 | 1 | a Spagnuolo, Carmelau University of Montreal, Canada4 aut |
700 | 1 | a Stafforini, Diana M.u University of Utah, UT USA4 aut |
700 | 1 | a Stagg, Johnu University of Utah, UT USA4 aut |
700 | 1 | a Subbarayan, Pochi R.u University of Montreal, Canada4 aut |
700 | 1 | a Sundin, Tabethau University of Miami, FL USA4 aut |
700 | 1 | a Talib, Wamidh H.u Sentara Healthcare, VA USA4 aut |
700 | 1 | a Thompson, Sarah K.u Appl Science University, Jordan4 aut |
700 | 1 | a Tran, Phuoc T.u Royal Adelaide Hospital, Australia4 aut |
700 | 1 | a Ungefroren, Hendriku Azienda Osped Ist Ospitalieri Cremona, Italy4 aut |
700 | 1 | a Vander Heiden, Matthew G.u MIT, MA 02139 USA4 aut |
700 | 1 | a Venkateswaran, Vasundarau Johns Hopkins University, MD USA; University of Toronto, Canada4 aut |
700 | 1 | a Vinay, Dass S.u Tulane University, LA USA4 aut |
700 | 1 | a Vlachostergios, Panagiotis J.u Johns Hopkins University, MD USA; New York University, NY USA4 aut |
700 | 1 | a Wang, Zongweiu Johns Hopkins University, MD USA; Harvard University, MA USA4 aut |
700 | 1 | a Wellendx, Kathryn E.u Columbia University, NY USA; University of Penn, PA 19104 USA4 aut |
700 | 1 | a Whelan, Richard L.u St Lukes Roosevelt Hospital, NY 10025 USA4 aut |
700 | 1 | a Yang, Eddy S.u University of Alabama Birmingham, AL USA4 aut |
700 | 1 | a Yang, Huanjieu Harbin Institute Technology, Peoples R China4 aut |
700 | 1 | a Yang, Xujuanu Dalhousie University, Canada4 aut |
700 | 1 | a Yaswen, Paulu Lawrence Berkeley National Lab, CA USA4 aut |
700 | 1 | a Yedjou, Clementu Jackson State University, MS USA4 aut |
700 | 1 | a Yin, Xinu Nara Medical University, Japan4 aut |
700 | 1 | a Zhu, Jiyueu Washington State University, WA USA4 aut |
700 | 1 | a Zollo, Massimou CSIC, Spain; Centre Ingn Genet and Biotecnol Avanzate, Italy4 aut |
710 | 2 | a Block Centre Integrat Cancer Treatment, IL 60077 USAb Block Centre Integrat Cancer Treatment, IL 60077 USA; National Cancer Centre, South Korea4 org |
773 | 0 | t Seminars in Cancer Biologyd : Academic Pressg 35, s. S276-S304q 35<S276-S304x 1044-579Xx 1096-3650 |
856 | 4 | u https://liu.diva-portal.org/smash/get/diva2:892966/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://doi.org/10.1016/j.semcancer.2015.09.007 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-123767 |
856 | 4 8 | u https://doi.org/10.1016/j.semcancer.2015.09.007 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:132616666 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.